Literature DB >> 18615140

Painful peripheral neuropathies.

P Marchettini1, M Lacerenza, E Mauri, C Marangoni.   

Abstract

Peripheral neuropathies are a heterogeneous group of diseases affecting peripheral nerves. The causes are multiple: hereditary, metabolic, infectious, inflammatory, toxic, traumatic. The temporal profile includes acute, subacute and chronic conditions. The majority of peripheral neuropathies cause mainly muscle weakness and sensory loss, positive sensory symptoms and sometimes pain. When pain is present, however, it is usually extremely intense and among the most disabling symptoms for the patients. In addition, the neurological origin of the pain is often missed and patients receive inadequate or delayed specific treatment. Independently of the disease causing the peripheral nerve injury, pain originating from axonal pathology or ganglionopathy privileges neuropathies affecting smaller fibres, a clinical observation that points towards abnormal activity within nociceptive afferents as a main generator of pain. Natural activation of blood vessels or perineurial nociceptive network by pathology also causes intense pain. Pain of this kind, i.e. nerve trunk pain, is among the heralding symptoms of inflammatory or ischemic mononeuropathy and for its intensity represents itself a medical emergency. Neuropathic pain quality rekindles the psychophysical experience of peripheral nerves intraneural microstimulation i.e. a combination of large and small fibres sensation temporally distorted compared to physiological perception evoked by natural stimuli. Pins and needles, burning, cramping mixed with numbness, and tingling are the wording most used by patients. Nociceptive pain instead is most often described as aching, deep and dull. Good command of peripheral nerve anatomy and pathophysiology allows timely recognition of the different pain components and targeted treatment, selected according to intensity, type and temporal profile of the pain.

Entities:  

Keywords:  Pain; diabetic neuropathy; hereditary neuropathy; neuropathic; paraneoplastic polyneuropathy; polyneuropathy; post herpetic neuralgia; small fibres neuropathy

Year:  2006        PMID: 18615140      PMCID: PMC2430688          DOI: 10.2174/157015906778019536

Source DB:  PubMed          Journal:  Curr Neuropharmacol        ISSN: 1570-159X            Impact factor:   7.363


  57 in total

1.  Clarifying the definition of neuropathic pain.

Authors:  Mitchell B Max
Journal:  Pain       Date:  2002-04       Impact factor: 6.961

2.  The natural history of herpes zoster.

Authors:  C F BURGOON; J S BURGOON; G D BALDRIDGE
Journal:  J Am Med Assoc       Date:  1957-05-18

3.  Diabetic amyotrophy.

Authors:  H GARLAND
Journal:  Br Med J       Date:  1955-11-26

Review 4.  The systemic amyloidoses.

Authors:  R H Falk; R L Comenzo; M Skinner
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

5.  Post-herpetic neuralgia: the relation of pain complaint, sensory disturbance, and skin temperature.

Authors:  Michael C Rowbotham; Howard L Fields
Journal:  Pain       Date:  1989-11       Impact factor: 6.961

6.  Hyperexcitable polymodal and insensitive nociceptors in painful human neuropathy.

Authors:  José L Ochoa; Mario Campero; Jordi Serra; Hugh Bostock
Journal:  Muscle Nerve       Date:  2005-10       Impact factor: 3.217

Review 7.  Diagnosis of hereditary neuropathies in adult patients.

Authors:  Davide Pareyson
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

8.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Epidemiology of shingles.

Authors:  C Glynn; G Crockford; D Gavaghan; P Cardno; D Price; J Miller
Journal:  J R Soc Med       Date:  1990-10       Impact factor: 18.000

View more
  27 in total

1.  Abnormal muscle afferent function in a model of Taxol chemotherapy-induced painful neuropathy.

Authors:  Xiaojie Chen; Paul G Green; Jon D Levine
Journal:  J Neurophysiol       Date:  2011-05-11       Impact factor: 2.714

2.  Comparison of 2 Multimodal Interventions With and Without Whole Body Vibration Therapy Plus Traction on Pain and Disability in Patients With Nonspecific Chronic Low Back Pain.

Authors:  Gianni F Maddalozzo; Brian Kuo; Walker A Maddalozzo; Conner D Maddalozzo; Johnny W Galver
Journal:  J Chiropr Med       Date:  2016-08-25

3.  Real-time, label-free, intraoperative visualization of peripheral nerves and micro-vasculatures using multimodal optical imaging techniques.

Authors:  Jaepyeong Cha; Aline Broch; Scott Mudge; Kihoon Kim; Jung-Man Namgoong; Eugene Oh; Peter Kim
Journal:  Biomed Opt Express       Date:  2018-02-12       Impact factor: 3.732

4.  Modulatory effects of photobiomodulation in the anterior cingulate cortex of diabetic rats.

Authors:  Igor Rafael Correia Rocha; Marucia Chacur
Journal:  Photochem Photobiol Sci       Date:  2021-05-30       Impact factor: 3.982

5.  Prevalence of musculoskeletal pain in association with serum 25-hydroxyvitamin D concentrations in patients with type 2 diabetes mellitus.

Authors:  Mohammad J Alkhatatbeh; Khalid K Abdul-Razzak; Lubna Q Khasawneh; Nesreen A Saadeh
Journal:  Biomed Rep       Date:  2018-04-26

6.  Characterisation of pain in people with hereditary neuropathy with liability to pressure palsy.

Authors:  Darren Beales; Robyn Fary; Cameron Little; Shruti Nambiar; Hakon Sveinall; Yen Leng Yee; Brigitte Tampin; Tim Mitchell
Journal:  J Neurol       Date:  2017-10-27       Impact factor: 4.849

7.  Neuropathic pain: is it an underestimated symptom in systemic sclerosis?

Authors:  Nihan Cuzdan; Ipek Turk; Tunay Sarpel; Eren Erken; Zeliha Nazan Alparslan
Journal:  Clin Rheumatol       Date:  2018-04-24       Impact factor: 2.980

Review 8.  The role of PPARγ in chemotherapy-evoked pain.

Authors:  Iryna A Khasabova; Virginia S Seybold; Donald A Simone
Journal:  Neurosci Lett       Date:  2021-03-24       Impact factor: 3.046

9.  Evidence for a novel subcortical mechanism for posterior cingulate cortex atrophy in HIV peripheral neuropathy.

Authors:  John R Keltner; Alan Tong; Eelke Visser; Mark Jenkinson; Colm G Connolly; Alyssa Dasca; Aleks Sheringov; Zachary Calvo; Earl Umbao; Rohit Mande; Mary Beth Bilder; Gagandeep Sahota; Donald R Franklin; Stephanie Corkran; Igor Grant; Sarah Archibald; Florin Vaida; Gregory G Brown; J Hampton Atkinson; Alan N Simmons; Ronald J Ellis
Journal:  J Neurovirol       Date:  2020-06-10       Impact factor: 3.739

10.  Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.

Authors:  C G Maihöfner; M-L S Heskamp
Journal:  Eur J Pain       Date:  2013-10-29       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.